Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bronwyn M. Gunn & Shuangyi Bai. (2021) Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection. Human Vaccines & Immunotherapeutics 17:11, pages 4328-4344.
Read now
Read now
Steffen Lippold, Alexander Knaupp, Arnoud H. de Ru, Rayman T. N. Tjokrodirijo, Peter A. van Veelen, Erwin van Puijenbroek, Steven W. de Taeye, Dietmar Reusch, Gestur Vidarsson, Manfred Wuhrer, Tilman Schlothauer & David Falck. (2021) Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography–mass spectrometry. mAbs 13:1.
Read now
Read now
Articles from other publishers (17)
Catherine M. Kasse, Anthony C. Yu, Abigail E. Powell, Gillie A. Roth, Celine S. Liong, Carolyn K. Jons, Awua Buahin, Caitlin L. Maikawa, Xueting Zhou, Sawsan Youssef, Jacob E. Glanville & Eric A. Appel. (2023) Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot. Biomaterials Science 11:6, pages 2065-2079.
Crossref
Crossref
Marco Troisi, Eleonora Marini, Valentina Abbiento, Samuele Stazzoni, Emanuele Andreano & Rino Rappuoli. (2022) A new dawn for monoclonal antibodies against antimicrobial resistant bacteria. Frontiers in Microbiology 13.
Crossref
Crossref
Sandra Lara, Juliane Heilig, Alexander Virtanen & Sandra Kleinau. (2022) Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma. BMC Cancer 22:1.
Crossref
Crossref
Harini Natarajan, Shiwei Xu, Andrew R. Crowley, Savannah E. Butler, Joshua A. Weiner, Evan M. Bloch, Kirsten Littlefield, Sarah E. Benner, Ruchee Shrestha, Olivia Ajayi, Wendy Wieland-Alter, David Sullivan, Shmuel Shoham, Thomas C. Quinn, Arturo Casadevall, Andrew Pekosz, Andrew D. Redd, Aaron A. R. Tobian, Ruth I. Connor, Peter F. Wright & Margaret E. Ackerman. (2022) Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2. BMC Immunology 23:1.
Crossref
Crossref
Cathrine Scheepers, Simone I. Richardson, Thandeka Moyo-Gwete & Penny L. Moore. (2022) Antibody class-switching as a strategy to improve HIV-1 neutralization. Trends in Molecular Medicine 28:11, pages 979-988.
Crossref
Crossref
Nikita N. Kostin, Tatiana V. Bobik, George A. Skryabin, Mariya A. Simonova, Vera D. Knorre, Victoria A. Abrikosova, Yuliana A. Mokrushina, Ivan V. Smirnov, Natalia L. Aleshenko, Natalia A. Kruglova, Dmitry V. Mazurov, Alexey E. Nikitin & Alexander G. Gabibov. (2022) An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity. Acta Naturae 14:3, pages 109-119.
Crossref
Crossref
Shuyu Huang, Aina Segués, Martin Waterfall, David Wright, Charlotte Vayssiere, Sander M. J. van Duijnhoven, Andrea van Elsas, Alice J. A. M. Sijts & Dietmar M. Zaiss. (2022) Shortened Hinge Design of Fab x sdAb-Fc Bispecific Antibodies Enhances Redirected T-Cell Killing of Tumor Cells. Biomolecules 12:10, pages 1331.
Crossref
Crossref
Ana Rita Cruz, Arthur E. H. Bentlage, Robin Blonk, Carla J. C. de Haas, Piet C. Aerts, Lisette M. Scheepmaker, Inge G. Bouwmeester, Anja Lux, Jos A. G. van Strijp, Falk Nimmerjahn, Kok P. M. van Kessel, Gestur Vidarsson & Suzan H. M. Rooijakkers. (2022) Toward Understanding How Staphylococcal Protein A Inhibits IgG-Mediated Phagocytosis. The Journal of Immunology 209:6, pages 1146-1155.
Crossref
Crossref
Siting Li, Jingjing Meng, Yanze Lv, Qian Wang, Xinping Tian, Mengtao Li, Xiaofeng Zeng, Chaojun Hu & Yuehong Zheng. (2022) Changes in Serum IgG Glycosylation Patterns for Abdominal Aortic Aneurysm Patients. Journal of Cardiovascular Development and Disease 9:9, pages 291.
Crossref
Crossref
Lisanne de Vor, Coco R. Beudeker, Anne Flier, Lisette M. Scheepmaker, Piet C. Aerts, Daniel C. Vijlbrief, Mireille N. Bekker, Frank J. Beurskens, Kok P. M. van Kessel, Carla J. C. de Haas, Suzan H. M. Rooijakkers & Michiel van der Flier. (2022) Monoclonal antibodies effectively potentiate complement activation and phagocytosis of Staphylococcus epidermidis in neonatal human plasma. Frontiers in Immunology 13.
Crossref
Crossref
Anja Werner & Falk Nimmerjahn. (2022) HINGEneering IgG for enhanced immune activation. Science Immunology 7:73.
Crossref
Crossref
Stian Foss, Alexandra Jonsson, Maria Bottermann, Ruth Watkinson, Heidrun E. Lode, Martin B. McAdamTerje E. Michaelsen, Inger SandlieLeo C. James & Jan Terje Andersen. (2022) Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. Science Immunology 7:70.
Crossref
Crossref
James E. CroweJr.Jr.. (2022) Human Antibodies for Viral Infections. Annual Review of Immunology 40:1, pages 349-386.
Crossref
Crossref
Elena Boero, Ana Rita Cruz, Werner Pansegrau, Cinzia Giovani, Suzan H. M. Rooijakkers, Kok P. M. van Kessel, Jos A. G. van Strijp, Fabio Bagnoli & Andrea G. O. Manetti. (2022) Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3. Frontiers in Immunology 13.
Crossref
Crossref
Simone I. Richardson, Frances Ayres, Nelia P. Manamela, Brent Oosthuysen, Zanele Makhado, Bronwen E. Lambson, Lynn Morris & Penny L. Moore. (2021) HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function. Frontiers in Immunology 12.
Crossref
Crossref
Kristen A. Clarkson, Chad K. Porter, Kawsar R. Talaat, Robert W. FrenckJr.Jr., Cristina Alaimo, Patricia Martin, A. Louis Bourgeois & Robert W. Kaminski. (2021)
Shigella
-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei
. mSphere 6:4.
Crossref
Crossref
David A. Spencer, Mariya B. Shapiro, Nancy L. Haigwood & Ann J. Hessell. (2021) Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic. Frontiers in Public Health 9.
Crossref
Crossref